Now, as 2021 begins, the author of today’s article believes that the “next decade could easily be the best decade, ever, for the stock market as post-war euphoria and easy money policy couple with multiple hypergrowth technological breakthroughs to rapidly unlock tremendous and widespread economic value.”
When it comes to biotech investing in 2021, healthcare stock analysts at RBC advised in a recent report that “Many pandemic-related influences are setting up the sector for outperformance but several factors could still work against the group, making individual stock selection a key priority…”
“Since we know small-cap stocks are hot and biotech stocks are as well, it might make sense to follow some smaller biotech penny stocks this month,”
On Monday, the small biotech stock highlighted in today’s article hit a record high, skyrocketing 95.1%. The catalyst?
November saw the FDA grant its first emergency use approval for an at-home, self-collected nasal swab test for COVID-19 and approve the first drugs for… Read More »These Biotechs Are Awaiting FDA Rulings In December
What is this investment opportunity that seems to check all the boxes?
Today’s article highlights a group of companies that tend to decline before an election – underperforming the stock market by over one-third as we move towards an election – and then recover.
One billion dollars. Big things happen when a company reaches this threshold in annual sales.
“The fact that more than 9 months of this year have been focused on the space is unfounded. In fact, I don’t remember one industry in recent history that has so captivated the stock market as much as this,” says the author of today’s article of the biotech space – and biotech penny stocks in particular.
While the surge in interest in pharmaceutical stocks this year has been primarily driven by factors related to the COVID-19 pandemic, the author of today’s article advises that “companies working on pharmaceutical products for unmet needs or other niche markets such as animal health could be worth a closer look.”